Literature DB >> 7853547

Roles of immunoglobulin valency and the heavy-chain constant domain in antibody-mediated downregulation of Sindbis virus replication in persistently infected neurons.

S Ubol1, B Levine, S H Lee, N S Greenspan, D E Griffin.   

Abstract

Clearance of infectious Sindbis virus from neurons is mediated by antibody to the E2 glycoprotein. Properties of the antibody important for downregulation of Sindbis virus replication are unknown. Immunoglobulin isotypes and valency determine many biological properties of antibodies. An immunoglobulin G1 (IgG1) isotype switch mutant and F(ab')2 and Fab fragments of IgG3 monoclonal antibody 209 were prepared and tested for clearance of infectious virus from persistently infected rat dorsal root ganglion neurons in vitro. IgG1, IgG3, and IgG3-derived F(ab')2 fragments were similarly efficacious, while IgG3-derived Fab fragments had no effect on virus replication. Cross-linking of Fab with secondary antibodies restored antiviral activity. Therefore, we found no evidence that IgG subclass plays a role in control of intracellular Sindbis virus replication. However, bivalency appears to be crucial for the ability of E2-specific IgG molecules to mediate clearance of infectious virus from neuron cells, suggesting that cross-linking of E2 molecules is essential.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7853547      PMCID: PMC188823     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  23 in total

1.  Basis of neurovirulence in Sindbis virus encephalomyelitis of mice.

Authors:  A C Jackson; T R Moench; B D Trapp; D E Griffin
Journal:  Lab Invest       Date:  1988-05       Impact factor: 5.662

2.  Isolation of immunoglobulin class switch variants from hybridoma lines secreting anti-idiotope antibodies by sequential sublining.

Authors:  C E Müller; K Rajewsky
Journal:  J Immunol       Date:  1983-08       Impact factor: 5.422

3.  Successful treatment of echovirus meningoencephalitis and myositis-fasciitis with intravenous immune globulin therapy in a patient with X-linked agammaglobulinemia.

Authors:  P J Mease; H D Ochs; R J Wedgwood
Journal:  N Engl J Med       Date:  1981-05-21       Impact factor: 91.245

4.  Successful reversal of echovirus encephalitis in X-linked hypogammaglobulinemia by intraventricular administration of immunoglobulin.

Authors:  K Erlendsson; T Swartz; J M Dwyer
Journal:  N Engl J Med       Date:  1985-02-07       Impact factor: 91.245

5.  Antigenic characterization of two sindbis envelope glycoproteins separated by isoelectric focusing.

Authors:  J M Dalrymple; S Schlesinger; P K Russell
Journal:  Virology       Date:  1976-01       Impact factor: 3.616

6.  Intracerebral cytokine mRNA expression during fatal and nonfatal alphavirus encephalitis suggests a predominant type 2 T cell response.

Authors:  S L Wesselingh; B Levine; R J Fox; S Choi; D E Griffin
Journal:  J Immunol       Date:  1994-02-01       Impact factor: 5.422

7.  Neurotransmitter synthesis by neuroblastoma clones (neuroblast differentiation-cell culture-choline acetyltransferase-acetylcholinesterase-tyrosine hydroxylase-axons-dendrites).

Authors:  T Amano; E Richelson; M Nirenberg
Journal:  Proc Natl Acad Sci U S A       Date:  1972-01       Impact factor: 11.205

8.  Alphavirus neurovirulence: monoclonal antibodies discriminating wild-type from neuroadapted Sindbis virus.

Authors:  J Stanley; S J Cooper; D E Griffin
Journal:  J Virol       Date:  1985-10       Impact factor: 5.103

9.  Monoclonal antibody cure and prophylaxis of lethal Sindbis virus encephalitis in mice.

Authors:  J Stanley; S J Cooper; D E Griffin
Journal:  J Virol       Date:  1986-04       Impact factor: 5.103

10.  IgG2a restriction of murine antibodies elicited by viral infections.

Authors:  J P Coutelier; J T van der Logt; F W Heessen; G Warnier; J Van Snick
Journal:  J Exp Med       Date:  1987-01-01       Impact factor: 14.307

View more
  29 in total

1.  Control of Sindbis virus infection by antibody in interferon-deficient mice.

Authors:  A P Byrnes; J E Durbin; D E Griffin
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Large-plaque mutants of Sindbis virus show reduced binding to heparan sulfate, heightened viremia, and slower clearance from the circulation.

Authors:  A P Byrnes; D E Griffin
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  A DNA prime, orally delivered protein boost vaccination strategy against viral encephalitis.

Authors:  Mark P Zanin; Diane E Webster; Steven L Wesselingh
Journal:  J Neurovirol       Date:  2007-06       Impact factor: 2.643

4.  Alphavirus-induced encephalomyelitis: antibody-secreting cells and viral clearance from the nervous system.

Authors:  Talibah U Metcalf; Diane E Griffin
Journal:  J Virol       Date:  2011-08-24       Impact factor: 5.103

5.  Treatment of mice with human monoclonal antibody 24h after lethal aerosol challenge with virulent Venezuelan equine encephalitis virus prevents disease but not infection.

Authors:  Ann R Hunt; Richard A Bowen; Shana Frederickson; Toshiaki Maruyama; John T Roehrig; Carol D Blair
Journal:  Virology       Date:  2011-04-13       Impact factor: 3.616

6.  Noncytolytic clearance of sindbis virus infection from neurons by gamma interferon is dependent on Jak/STAT signaling.

Authors:  Rebeca Burdeinick-Kerr; Dhanasekaran Govindarajan; Diane E Griffin
Journal:  J Virol       Date:  2009-01-28       Impact factor: 5.103

Review 7.  Immunotherapy for neurodegenerative diseases: focus on α-synucleinopathies.

Authors:  Elvira Valera; Eliezer Masliah
Journal:  Pharmacol Ther       Date:  2013-02-04       Impact factor: 12.310

8.  Effects of anti-E2 monoclonal antibody on sindbis virus replication in AT3 cells expressing bcl-2.

Authors:  P Després; J W Griffin; D E Griffin
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

Review 9.  Recovery from viral encephalomyelitis: immune-mediated noncytolytic virus clearance from neurons.

Authors:  Diane E Griffin
Journal:  Immunol Res       Date:  2010-07       Impact factor: 2.829

10.  Virus-neutralizing activity mediated by the Fab fragment of a hemagglutinin-specific antibody is sufficient for the resolution of influenza virus infection in SCID mice.

Authors:  Krystyna Mozdzanowska; Jingqi Feng; Walter Gerhard
Journal:  J Virol       Date:  2003-08       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.